Recent studies have demonstrated that NAT10 plays a pivotal role in the development of colon cancer by affecting the stability of FSP1 mRNA and ferroptosis, underscoring its potential as a new prognostic and therapeutic target for colon cancer [18]. This evidence concerns the gene NAT10 and colonic neoplasm.